Post hoc analyses in sepsis trials: a formula for disappointment?
Dellinger
R P
RP
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D003627:Data Interpretation, Statistical; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D011446:Prospective Studies; D018805:Sepsis / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D014409:Tumor Necrosis Factor-alpha